<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-85801</identifier>
<setSpec>0003-3170</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Factors infl uencing the physician disposition to treat with a therapy with proven but low effi cacy: The case of endarterectomy for severe asymptomatic carotid stenosis</dc:title>
<dc:description xml:lang="en">Conclusions. The proven but low effi cacy of some treatments, such as carotid endarterectomyfor severe asymptomatic stenosis, seems to be due to contingent factors infl uencing the fi naldecision to treat. The identifi cation of subgroups of patients with higher therapeutic benefi twould probably decrease the importance of those factors in clinical decision-making(AU)</dc:description>
<dc:creator>Llort Pont, C</dc:creator>
<dc:creator>Vidal-Barraquer Mayol, F</dc:creator>
<dc:creator>Clará Velasco, A</dc:creator>
<dc:creator>Ois Santiago, Á</dc:creator>
<dc:creator>Calsina Juscafresa, L</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Conclusiones. La discreta rentabilidad de determinados tratamientos, como la revascularizacióncarotídea en estenosis asintomáticas, tiende a favorecer que emerjan factores contingentes enla decisión que, probablemente, serían poco relevantes en terapéuticas con un benefi cio másmarcado. La identifi cación de subgrupos de pacientes con mayor benefi cio terapéutico limitaría,con toda seguridad, la infl uencia de estos imponderables(AU)</dc:description>
<dc:source>Angiologia;62(1): 14-19, ene.-feb. 2010. tab, graf</dc:source>
<dc:identifier>ibc-85801</dc:identifier>
<dc:title xml:lang="es">¿Qué factores infl uyen en la predisposición terapéutica ante tratamientos de efi cacia demostrada pero discreta? El caso de la revascularización en la estenosis carotídea grave asintomática</dc:title>
<dc:subject>^d30132^s22020</dc:subject>
<dc:subject>^d30211^s22012</dc:subject>
<dc:subject>^d30211^s22067</dc:subject>
<dc:subject>^d26352^s22083</dc:subject>
<dc:subject>^d30132^s22074</dc:subject>
<dc:subject>^d24769</dc:subject>
<dc:subject>^d^s22083</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d28608^s22074</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:type>article</dc:type>
<dc:date>201002</dc:date>
</metadata>
</record>
</ibecs-document>
